Skip to main content

New B-Cell Depleting Agent Is Well Tolerated : TRU-015 resulted in ACR20 improvement in half of 36 patients studied; 25% had ACR50 responses.

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
New B-Cell Depleting Agent Is Well Tolerated : TRU-015 resulted in ACR20 improvement in half of 36 patients studied; 25% had ACR50 responses.

User login

Username

Password

Reset your password

Type	Lead	score